Specialty Pharmacy

Treatment with cord blood-derived chimeric antigen receptor natural killer-cell therapy targeting CD19 resulted in clinical responses in relapsed or refractory non-Hodgkin’s lymphoma and chronic lymphocytic leukemia.

Top News of the Week from Directions in Specialty Pharmacy

Top news from across the health care landscape.

A study offers evidence that chimeric antigen receptor T-cell therapy may not only extend patients’ survival, but also improve their quality of life after treatment.

Top news from across the health care landscape.

AL101 is a potent, selective, injectable small molecule gamma secretase inhibitor and was granted Orphan Drug designation in May 2019 for the treatment of ACC.

Pharmacists should be aware of what drug repurposing is and how it occurs as due to the vast amount of opportunities that exist.

Top news from across the health care landscape.

The designation was granted to Emerald Health Pharmaceuticals’ EHP-101, an oral formulation of a novel aminoquinone synthetic derivative of cannabidiol endowed with dual peroxisome proliferator-activated receptor gamma and cannabinoid receptor type 2 agonist activity.

Depending on the amount consumed, intake of dairy milk can increase the risk of breast cancer by up to 80%, according to new research from Loma Linda University Health.

Top News of the Week from Directions in Specialty Pharmacy.

In order to increase the effectiveness of adherence interventions, we need to take into account the fact that human beings are not always rational.

This is the first newly approved therapy for high risk locally advanced squamous cell carcinoma of LA-SCCHN in 25 years.

Top news from across the health care landscape.

Top news from across the health care landscape.

A recent patient survey conducted by Human Care Services uncovered a genuine significant desire from patients for help from drug manufacturers in managing their conditions and drug regimens.

Top news from across the health care landscape.

The research resulted in nearly 50 new drugs with previously unrecognized anti-cancer activity.

Top news from across the health care landscape.

The Masters in Pharmacy Business Administration program is designed for emerging pharmacy professionals seeking executive positions who are interested in obtaining an in-depth understanding of the business of pharmaceuticals.

Monotherapy with talazoparib demonstrated encouraging antitumor activity in patients with DNA damage repair mutations and docetaxel pretreated metastatic castration-resistant prostate cancer.

Patients with ulcerative colitis have an increased risk of developing colorectal cancer (CRC), are diagnosed with less advanced CRC, and are at increased risk of death from CRC.

Top news of week from Specialty Pharmacy Times.

Top news from across the health care landscape.

Patients diagnosed with Crohn disease and colorectal cancer (CRC) have a higher rate of mortality than patients without Crohn disease who are also diagnosed with CRC.

In a Directions in Oncology PharmacyTM Peer Exchange series, experts explained the right time to use bevacizumab, either as a front-line therapy or at the time of disease progression.

In recent history, drug shortages became somewhat of a phenomenon, tripling from 61 shortages in 2005 to 178 in 2010.

In a Directions in Oncology Pharmacy Peer Exchange series, experts discuss the PRIMA trial and the rationale for using PARP inhibitors.